Towards a human oral vaccine for anthrax: the utility of a Salmonella Typhi Ty21a-based prime-boost immunization strategy
about
Salmonella as a vaccine delivery vehicleCD4+ T Cells Targeting Dominant and Cryptic Epitopes from Bacillus anthracis Lethal FactorPrinciples of antidote pharmacology: an update on prophylaxis, post-exposure treatment recommendations and research initiatives for biological agentsAnthrax vaccination strategiesA new generation of stable, nonantibiotic, low-copy-number plasmids improves immune responses to foreign antigens in Salmonella enterica serovar Typhi live vectorsMucosal priming of newborn mice with S. Typhi Ty21a expressing anthrax protective antigen (PA) followed by parenteral PA-boost induces B and T cell-mediated immunity that protects against infection bypassing maternal antibodiesAn anthrax subunit vaccine candidate based on protective regions of Bacillus anthracis protective antigen and lethal factor.Live bacterial vaccine vectors: an overview.Quantitative anti-PA IgG ELISA; assessment and comparability with the anthrax toxin neutralization assay in goats.Salmonella enterica serovar Typhi live vector vaccines finally come of ageDNA vaccines for targeting bacterial infections.Live, attenuated strains of Listeria and Salmonella as vaccine vectors in cancer treatment.Therapeutic live vaccines as a potential anticancer strategy.Intracellular delivery of biologic therapeutics by bacterial secretion systems.Protection against inhalation anthrax by immunization with Salmonella enterica serovar Typhi Ty21a stably producing protective antigen of Bacillus anthracis.Can one size fit all? Towards a universal anthrax vaccine.
P2860
Q27011946-F26D2EF3-1F29-42C9-B603-5118F941F455Q28383022-3CB1D984-3147-4119-8142-0F96708B4BCFQ28384852-4C568844-0275-4640-AC8B-7AB901933840Q28392248-C437D221-C13A-4AB0-9345-0DF84FCF5F99Q33557714-B074C649-B414-4DE8-8C20-8901802F5429Q34121874-AA2652F7-7CFC-4152-A49B-C77B7A6276E8Q34433313-57C66783-5584-4234-86BF-9384F12A7607Q35068970-90C8A7D8-3FDD-42D0-907B-BB1676030E83Q35077052-72A9D019-4C03-46D8-B711-F1AC3FA9E519Q37106127-414EBF53-61D8-4B62-9F0E-9AC0149EA080Q37771943-BFD92151-BD3A-4C15-9112-FB856E0A195FQ37843660-662E8BC4-FAB0-4E64-A5F3-DC25DD385B90Q38011653-71AE677E-6D25-4B05-B97A-75D27EB7A747Q38734240-2A8139B9-F456-4D69-97B2-1E1156FEBF69Q47162390-2536FE99-C1BD-4248-9DFA-DB41CCAE6193Q47250394-EE9503AF-0695-4211-BD57-9DD9EB58A5CC
P2860
Towards a human oral vaccine for anthrax: the utility of a Salmonella Typhi Ty21a-based prime-boost immunization strategy
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Towards a human oral vaccine f ...... me-boost immunization strategy
@ast
Towards a human oral vaccine f ...... me-boost immunization strategy
@en
Towards a human oral vaccine f ...... me-boost immunization strategy
@nl
type
label
Towards a human oral vaccine f ...... me-boost immunization strategy
@ast
Towards a human oral vaccine f ...... me-boost immunization strategy
@en
Towards a human oral vaccine f ...... me-boost immunization strategy
@nl
prefLabel
Towards a human oral vaccine f ...... me-boost immunization strategy
@ast
Towards a human oral vaccine f ...... me-boost immunization strategy
@en
Towards a human oral vaccine f ...... me-boost immunization strategy
@nl
P2093
P2860
P1433
P1476
Towards a human oral vaccine f ...... me-boost immunization strategy
@en
P2093
Ana L Rodriguez
Chiguang Feng
Helen S Atkins
Leslie W J Baillie
Marcela F Pasetti
Stephen Moore
P2860
P304
P356
10.1016/J.VACCINE.2008.09.010
P407
P577
2008-09-19T00:00:00Z